(MedPage Today) — Chimeric antigen receptor (CAR) T-cell therapy for blood cancers appeared less toxic, and patients’ hospital stays were days shorter, when they also had autoimmune disease before starting the treatment, a large retrospective…
Source link : https://www.medpagetoday.com/hematologyoncology/hematology/118046
Author :
Publish date : 2025-10-20 20:48:00
Copyright for syndicated content belongs to the linked Source.
